Ignite Creation Date:
2024-05-06 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 12:45 PM
Study NCT ID:
NCT03512314
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-11-08
First Post:
2018-04-09
Brief Title:
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency as Open Label Extension
Sponsor:
AB2 Bio Ltd
Organization:
AB2 Bio Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| XIAP Deficiency |
| NLRC4-MAS |
Keywords: